Ruffelli M - Search Results

1

Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus.

De Pità O, Bellucci AM, Ruffelli M, Girardelli CR, Puddu P. De Pità O, et al. Among authors: ruffelli m. Lupus. 1997;6(4):415-7. doi: 10.1177/096120339700600414. Lupus. 1997. PMID: 9175031 Clinical Trial. No abstract available.

2

Intravenous immunoglobulin therapy: modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus.

Puddu P, De Pità O, Ruffelli M, Bellucci AM, Girardelli CR, Galeazzi M, Marcolongo R. Puddu P, et al. Among authors: ruffelli m. Arthritis Rheum. 1996 Apr;39(4):704-5. doi: 10.1002/art.1780390426. Arthritis Rheum. 1996. PMID: 8630125 No abstract available.

3

Repeat skin biopsies of nonlesional skin in patients with systemic lupus erythematosus.

Galeazzi M, Tuzi T, De Pita O, Ruffelli M, Sarti P. Galeazzi M, et al. Among authors: ruffelli m. Arthritis Rheum. 1983 Oct;26(10):1294-5. doi: 10.1002/art.1780261025. Arthritis Rheum. 1983. PMID: 6626291 No abstract available.

4

Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis.

Pallotta P, Cianchini G, Ruffelli M, Puddu P. Pallotta P, et al. Among authors: ruffelli m. Rheumatology (Oxford). 2006 Jan;45(1):116-7. doi: 10.1093/rheumatology/kei227. Epub 2005 Nov 30. Rheumatology (Oxford). 2006. PMID: 16319094 No abstract available.

5

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention.

Bottari V, Frezzolini A, Ruffelli M, Puddu P, Fontana L, De Pità O. Bottari V, et al. Among authors: ruffelli m. Allergy. 1999 May;54(5):507-10. doi: 10.1034/j.1398-9995.1999.00958.x. Allergy. 1999. PMID: 10380784 Clinical Trial.

6

T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).

De Pitá O, Frezzolini A, Cianchini G, Ruffelli M, Teofoli P, Puddu P. De Pitá O, et al. Among authors: ruffelli m. Arch Dermatol Res. 1997 Nov;289(12):667-70. doi: 10.1007/s004030050259. Arch Dermatol Res. 1997. PMID: 9452886

7

Interleukin-16 expression and release in bullous pemphigoid.

Frezzolini A, Cianchini G, Ruffelli M, Cadoni S, Puddu P, De Pità O. Frezzolini A, et al. Among authors: ruffelli m. Clin Exp Immunol. 2004 Sep;137(3):595-600. doi: 10.1111/j.1365-2249.2004.02570.x. Clin Exp Immunol. 2004. PMID: 15320912 Free PMC article.

8

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.

Frezzolini A, Teofoli P, Cianchini G, Barduagni S, Ruffelli M, Ferranti G, Puddu P, De Pita O. Frezzolini A, et al. Among authors: ruffelli m. Eur J Dermatol. 2002 Jan-Feb;12(1):27-31. Eur J Dermatol. 2002. PMID: 11809592

9

Dyshidrosiform palmoplantar pemphigoid in a young man: response to dapsone.

Lupi F, Masini C, Ruffelli M, Puddu P, Cianchini G. Lupi F, et al. Among authors: ruffelli m. Acta Derm Venereol. 2010;90(1):80-1. doi: 10.2340/00015555-0734. Acta Derm Venereol. 2010. PMID: 20107732 Free article. No abstract available.

10

Soluble CD30 in pediatric patients with atopic dermatitis.

Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pità O. Frezzolini A, et al. Among authors: ruffelli m. Allergy. 1997 Jan;52(1):106-9. doi: 10.1111/j.1398-9995.1997.tb02554.x. Allergy. 1997. PMID: 9062638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters